Steven M. Grauer

1.1k citations

14 papers · 788 indexed · h-index 11

Cellular and Molecular Neuroscience top 5%
- Neurotransmitter Receptor Influence on Behavior 4
- Neuropeptides and Animal Physiology 3
- Neuroscience and Neuropharmacology Research 2
Behavioral Neuroscience top 10%
Pharmacology top 10%
- Cholinesterase and Neurodegenerative Diseases 4
Biological Psychiatry
Endocrine and Autonomic Systems top 10%
Molecular Biology
- Receptor Mechanisms and Signaling 6
- Nicotinic Acetylcholine Receptors Study 3
- Ion channel regulation and function 1
Physiology
- Pain Mechanisms and Treatments 2

Co-authors: Karen L. Marquis Sheree F. Logue Radka Graf Thomas A. Comery Sharon Rosenzweig‐Lipson Julie Brennan Cody Kelley Nicholas J. Brandon
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Pharmacology
Partner nations: United States Canada Italy

In The Last Decade

Steven M. Grauer

14 papers receiving 768 citations

Peers

Countries citing papers authored by Steven M. Grauer

Since Specialization

Citations

This map shows the geographic impact of Steven M. Grauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Grauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Grauer more than expected).

Fields of papers citing papers by Steven M. Grauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Grauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Grauer. The network helps show where Steven M. Grauer may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven M. Grauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven M. Grauer Line = papers co-authored together Steven M. Grauer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work
1	Antinociceptive effects of potent, selective and brain penetrant muscarinic M4 positive allosteric modulators in rodent pain models Steven M. Grauer,Raul Sanoja,Dominic Poulin,Harunor Rashid,Nina Jochnowitz,Michael E. Calhoun,Daniel Zwilling,Geoffrey B. Varty,Thomas W. Rosahl,Hamid Méziane,Christopher Mittlelhaeuser,Robert Mazzola,John A. Morrow,Sean M. Smith,Darrell A. Henze,Jacob Marcus	2020	2
2	MitoPark mice, an animal model of Parkinson’s disease, show enhanced prepulse inhibition of acoustic startle and no loss of gating in response to the adenosine A2A antagonist SCH 412348 Steven M. Grauer,Robert A. Hodgson,Lynn A. Hyde	2013	11
3	Preclinical assessment of an adjunctive treatment approach for cognitive impairment associated with schizophrenia using the alpha7 nicotinic acetylcholine receptor agonist WYE-103914/SEN34625 Karen L. Marquis,Thomas A. Comery,Flora Jow,Rachel L. Navarra,Steven M. Grauer,Claudine Pulicicchio,Cody Kelley,Julie Brennan,Renza Roncarati,Carla Scali,Simon N. Haydar,Chiara Ghiron,Georg C. Terstappen,John Dunlop	2011	15
4	Procognitive and Neuroprotective Activity of a Novel α7 Nicotinic Acetylcholine Receptor Agonist for Treatment of Neurodegenerative and Cognitive Disorders Renza Roncarati,Carla Scali,Thomas A. Comery,Steven M. Grauer,Suzan Aschmi,Hendrick Bothmann,Brian Jow,Dianne Kowal,Marco Gianfriddo,Cody Kelley,Ugo Zanelli,Chiara Ghiron,Simon N. Haydar,John Dunlop,Georg C. Terstappen	2009	88
5	The orphan GPCR, GPR88, modulates function of the striatal dopamine system: A possible therapeutic target for psychiatric disorders? Sheree F. Logue,Steven M. Grauer,Janet Paulsen,Radka Graf,Noël Taylor,Mei-Li Amy Sung,Lynn Zhang,Zoë A. Hughes,Virginia Pulito,Feng Liu,Sharon Rosenzweig‐Lipson,Nicholas J. Brandon,Karen L. Marquis,Brian Bates,Mark Pausch	2009	70
6	Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia Steven M. Grauer,Virginia Pulito,Rachel L. Navarra,Michy P. Kelly,Cody Kelley,Radka Graf,Barbara Langen,Sheree F. Logue,Julie Brennan,Lixin Jiang,Erik I. Charych,Ute Egerland,Feng Liu,Karen L. Marquis,Michael S. Malamas,Thorsten Hage,Thomas A. Comery,Nicholas J. Brandon	2009	223
7	Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist Robert H. Ring,Lee E. Schechter,Sarah K. Leonard,Jason M. Dwyer,Brian J. Platt,Radka Graf,Steven M. Grauer,Claudine Pulicicchio,Lynn Resnick,Zia Ur Rahman,Stacey J. Sukoff Rizzo,Bin Luo,Chad E. Beyer,Sheree F. Logue,Karen L. Marquis,Zoë A. Hughes,Sharon Rosenzweig‐Lipson	2009	124
8	WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics Steven M. Grauer,Radka Graf,Rachel L. Navarra,Amy Sung,Sheree F. Logue,Gary Stack,Christine Huselton,Zhi Liu,Thomas A. Comery,Karen L. Marquis,Sharon Rosenzweig‐Lipson	2008	18
9	Old and New Pharmacology: Positive Allosteric Modulation of the α7 Nicotinic Acetylcholine Receptor by the 5-Hydroxytryptamine2B/C Receptor Antagonist SB-206553 (3,5-Dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b′]di pyrrole-1(2 H)-carboxamide) John Dunlop,Tim Lock,Brian Jow,Fabrizio Sitzia,Steven M. Grauer,Flora Jow,Angela Krämer,Mark R. Bowlby,Andrew D. Randall,Dianne Kowal,A. Gilbert,Thomas A. Comery,James LaRocque,Veronica Soloveva,Jon T. Brown,Renza Roncarati	2008	56
10	P.3.d.019 Vabicaserin: effects of a novel 5-HT2C agonist on medial prefrontal cortex neurotransmission, cognition and sensorimotor gating Sharon Rosenzweig‐Lipson,Carlos Beyer,Zoë A. Hughes,Qiaoyuan Lin,M.Y. Zhang,Steven M. Grauer,Suzan Aschmies,Thomas A. Comery,Gary Stack,Karen L. Marquis	2007	3
11	WAY-163909 [(7 bR,10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity Karen L. Marquis,Annmarie L. Sabb,Sheree F. Logue,Julie Brennan,Michael J. Piesla,Tom Comery,Steven M. Grauer,Charles R. Ashby,Huy Q. Nguyen,Lee A. Dawson,James E. Barrett,Gary Stack,Herbert Y. Meltzer,Boyd L. Harrison,Sharon Rosenzweig‐Lipson	2006	118
12	Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats Steven M. Grauer,Karen L. Marquis	1999	24
13	Morphine induces an increase in extracellular serotonin in the rat diencephalon Steven M. Grauer,Rui Tao,Sidney B. Auerbach	1992	34
14	Microdialysis measurement of serotonin release in the central nervous system Sidney B. Auerbach,Lynn O. Wilkinson,Rui Tao,Steven M. Grauer,John J. Rutter	1992	2

About Steven M. Grauer

Steven M. Grauer is a scholar working on Biological Psychiatry, Cellular and Molecular Neuroscience and Pharmacology, having authored 14 papers that have together received 788 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (6 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Neuropeptides and Animal Physiology (3 papers), Pain Mechanisms and Treatments (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Ion channel regulation and function (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (357 citations), Behavioral Neuroscience (44 citations) and Pharmacology (171 citations). Steven M. Grauer has collaborated with scholars based in United States, Canada and Italy. Frequent co-authors include Karen L. Marquis, Sheree F. Logue, Radka Graf, Thomas A. Comery, Sharon Rosenzweig‐Lipson, Julie Brennan, Cody Kelley, Nicholas J. Brandon, Virginia Pulito and Rachel L. Navarra.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact